You are here: Home » 0 » » Archives for 0st

2023 Digital Therapeutics Alliance Inaugural Summit: DTx Industry Leaders Gather to Transform Global Healthcare

Arlington, VA, March 30, 2023 (GLOBE NEWSWIRE) — The Digital Therapeutics Alliance (DTA) is hosting its Inaugural Summit on June 7–9, 2023 at the Washington Marriott at Metro Center. Leaders from all facets of the digital therapeutics (DTx) ecosystem, including policymakers, clinicians, and payors, will join DTA members to discuss the challenges and opportunities of DTx integration into the healthcare system and identify optimized policy, reimbursement, and regulatory pathways to accelerate adoption.

The 3–day Summit programming will be facilitated by Andy Molnar, Chief Executive Officer of DTA, and feature keynote presentations, panel discussions, and interactive sessions that cover the advancement of DTx, the impact of healthcare policy, reimbursement and regulatory pathways, clinical evidence requirements, and patient access optimization.

DTA's Chief Executive Officer, Andy Molnar states: "We are here to transform healthcare and deliver a new category of medicine to patients to improve their lives. The 2023 DTA Inaugural Summit brings together the leaders in healthcare innovation that are making these monumental changes. We are building viable frameworks with partners from Capitol Hill, the investment ecosystem, clinicians, health plans, patients, and caregivers."

DTx products use evidence–based, clinically evaluated technologies to optimize clinical and health economic outcomes, deliver high quality therapies to underserved populations, and transform how patients understand, manage, and engage in their healthcare.

Leading into the Summit, US–focused DTA members and staff will convene in Washington D.C. to meet with congressional members and other influential parties to advocate for the Access to Prescription Digital Therapeutics Act (S. 723 and H.R. 1458).This bill seeks to create a new benefit category for digital therapeutics and ensure permanent coverage and reimbursement of DTx products by Medicare and Medicaid.

Everett Crosland, DTA board member and Chief Commercial Officer for Cognito Therapeutics, commented, "Given the rapidly evolving reimbursement environment, DTA's 2023 Inaugural Summit offers the DTx industry an unprecedented opportunity to engage and advocate on the issues that matter most to our companies, patients, providers, and payor partners. I'm excited to speak about the emerging frameworks that are shaping our future."

Event details and registration: 2023 DTA Inaugural Summit

About DTA:

The Digital Therapeutics Alliance (DTA) is a global non–profit trade association of industry leaders and stakeholders with the mission of broadening the understanding, adoption, and integration of digital therapeutics into healthcare. DTA works to enable expanded access to high quality, evidence–based digital therapeutics for patients, clinicians, and payors to improve clinical and health economic outcomes. To learn more, please visit: www.dtxalliance.org and follow us on LinkedIn.

Attachment


GLOBENEWSWIRE (Distribution ID 8799236)

The Coretec Group Announces Two Upcoming Broadcast Calls

ANN ARBOR, Mich., March 30, 2023 (GLOBE NEWSWIRE) — The Coretec Group (OTCQB: CRTG), developers of silicon anode active materials for lithium–ion batteries and cyclohexasilane (CHS) for EV, cleantech, and emerging tech applications, today announced that it will host and participate in two upcoming calls – one being a shareholder call addressing shareholder questions, reflecting on recent achievements and demonstrating the path forward, and the second focused on the current battery landscape with energy storage industry leaders.

The shareholder call will take place on Thursday, May 18th at 10:00 am ET and will be led by CEO Matt Kappers and VP of Partnerships and Innovation, Dr. Michelle Tokarz. It will outline advancements made within Coretec's Endurion battery development program for EV application, IP updates, and clear next steps for the Company as it moves forward in the commercialization of its product.

The technology call will center more on industry happenings, hurdles, and advancements related to the manufacturing, supply chain, and commercialization of next generation EV batteries, giving the Endurion team the opportunity to discuss their solution. The Company will share an announcement about this call, which will include members of other organizations and an independent host, in the coming weeks.

Both calls are intended to inform shareholders and partners, and highlight Coretec's suite of technology products, as well as the critical market needs it seeks to address.

The Company will provide call access information via press release and social media in advance of the calls. Please follow on Twitter at @CoretecGroupInc or the Company's LinkedIn page.

About The Coretec Group

The Coretec Group, Inc. is developing a portfolio of engineered silicon to improve energy–focused verticals, including electric vehicle and consumer batteries, solid–state lighting (LEDs), and semiconductors, as well as 3D volumetric displays and printable electronics. The Coretec Group serves the global technology markets in energy, electronics, semiconductor, solar, health, environment, and security.

For more information, please visit thecoretecgroup.com.

Follow The Coretec Group on:

Twitter "" @CoretecGroupInc
LinkedIn "" www.linkedin.com/company/24789881
YouTube "" www.youtube.com/channel/UC1IA9C6PoPd1G4M7B9QiZPQ/featured

Forward–Looking Statements

The statements in this press release that relate to The Coretec Group's expectations with regard to the future impact on the Company's results from operations are forward–looking statements and may involve risks and uncertainties, some of which are beyond our control. Such risks and uncertainties are described in greater detail in our filings with the U.S. Securities and Exchange Commission. Since the information in this press release may contain statements that involve risk and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results. We make no commitment to disclose any subsequent revisions to forward–looking statements. This release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity.

Corporate Contact:

The Coretec Group, Inc.
Lindsay McCarthy
info@thecoretecgroup.com
+1 (866) 916–0833

Media Contact:

Spencer Herrmann
FischTank PR
coretec@fischtankpr.com
+1 (518) 669–6818


GLOBENEWSWIRE (Distribution ID 8798974)